OUR HISTORY

2017

Two Complementary companies, Boehringer Ingelheim and Merial, unite through a passion for animals and a joint history of integrity, quality and trust.

Boehringer Ingelheim becomes the 2nd global player in animal health.

2015

Boehringer Ingelheim enters into exclusive negotiations with Sanofi consisting of a strategic exchange of their consumer healthcare business for Merial.

2012

Boehringer Ingelheim Animal Health surpasses $1 billion in sales for the first time.

2009

Merial becomes a wholly-owned subsidiary of Sanofi.

1997

Merial was created through the merger of Rhône Mérieux (Rhône-Poulenc, France) and MSD AgVet (Merck & Co, US)

1981

Boehringer Ingelheim expands animal health operations in the United States with the acquisition of Philips Roxane.

1959

Achor Serum Company is acquired by North American Philips, later known as Philips Roxane.

1955

Boehringer Ingelheim's Animal Health division was established as the company takes over Pfizer's veterinary program.

1917

W. True Davis develops first hog cholera vaccine in St. Joseph, MO, and establishes Anchor Serum Company in the United States.

1897

Merieux founded the Institut Biologique Merleux (Merieux Bilogical Institute), in Lyon, France. This early vaccine research and production center was the starting point for the animal health endeavors that would one day become the company Merial.

1885

A family-owned company with 28 employees, headquartered in Ingelheim, Germany was founded by Albert Boehringer.